These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22422806)

  • 81. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
    Wang Y; Huang Q; Deng T; Li BH; Ren XQ
    Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma.
    Li W; Cai HX; Ge XM; Li K; Xu WD; Shi WH
    Tumour Biol; 2013 Apr; 34(2):669-74. PubMed ID: 23179403
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evaluation of Jagged2 and Gli1 expression and their correlation with prognosis in human hepatocellular carcinoma.
    Zhang J; Tu K; Yang W; Li C; Yao Y; Zheng X; Liu Q
    Mol Med Rep; 2014 Aug; 10(2):749-54. PubMed ID: 24858621
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma.
    Zheng W; Yao M; Sai W; Qian Q; Pan L; Qiu L; Huang J; Wu W; Yao D
    Tumour Biol; 2016 Jan; 37(1):999-1008. PubMed ID: 26264614
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance.
    Lin SB; Zhou L; Liang ZY; Zhou WX; Jin Y
    J Clin Pathol; 2017 Sep; 70(9):754-759. PubMed ID: 28202495
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Expression and clinicopathological significance of GRAMD4 in hepatocellular carcinoma].
    Zhang J; Tu K; Zhou Z; Zheng X; Gao J; Yao Y; Liu Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):190-3. PubMed ID: 23388340
    [TBL] [Abstract][Full Text] [Related]  

  • 87. SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules.
    Quagliata L; Andreozzi M; Kovac M; Tornillo L; Makowska Z; Moretti F; Heim MH; Heinimann K; Piscuoglio S; Terracciano LM
    Eur J Cancer; 2014 Mar; 50(4):731-8. PubMed ID: 24315626
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
    Ma X; Ding Y; Zeng L
    BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Increased DJ-1 and its prognostic significance in hepatocellular carcinoma.
    Liu S; Yang Z; Wei H; Shen W; Liu J; Yin Q; Li X; Yi J
    Hepatogastroenterology; 2010; 57(102-103):1247-56. PubMed ID: 21410067
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Correlation between serum anti-P53 and familial clustering of hepatocellular carcinoma in Guangxi].
    Pang Y; Li GJ; Wu JZ; Wu JL; Chen WQ; Ning QY; Wei YH; Hu DF; Qin L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):206-9. PubMed ID: 22487835
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Downregulation of FOXP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma by Inducing G1/S Phase Cell Cycle Arrest.
    Wang X; Sun J; Cui M; Zhao F; Ge C; Chen T; Yao M; Li J
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618020
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma.
    Li YC; Wang D; Zhu GY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4855-4860. PubMed ID: 30070318
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.
    Yu GR; Kim SH; Park SH; Cui XD; Xu DY; Yu HC; Cho BH; Yeom YI; Kim SS; Kim SB; Chu IS; Kim DG
    Exp Mol Med; 2007 Oct; 39(5):641-52. PubMed ID: 18059140
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Expression of multi-drug resistance-related genes MDR3 and MRP as prognostic factors in clinical liver cancer patients.
    Yu Z; Peng S; Hong-Ming P; Kai-Feng W
    Hepatogastroenterology; 2012; 59(117):1556-9. PubMed ID: 22366465
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis.
    Shi W; Hu J; Zhu S; Shen X; Zhang X; Yang C; Gao H; Zhang H
    Int J Clin Exp Pathol; 2015; 8(10):13083-9. PubMed ID: 26722504
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Copy number aberrations of genes related to extrohepatic metastasis-free survival after operation for hepatocellular carcinoma].
    Bao LL; Zhu ZZ; Wen BJ; Wan XX; Ye YQ; Chen L; He SQ; Cong WM
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):349-353. PubMed ID: 28763841
    [No Abstract]   [Full Text] [Related]  

  • 97. C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
    Chen J; Chen J; Gong Y; Zou B; Liu X; Ding L; Huang J; Zhang B; Li J
    J Invest Surg; 2020 Dec; 33(10):914-923. PubMed ID: 30907217
    [No Abstract]   [Full Text] [Related]  

  • 98. Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas.
    Fox SB; Brown P; Han C; Ashe S; Leek RD; Harris AL; Banham AH
    Clin Cancer Res; 2004 May; 10(10):3521-7. PubMed ID: 15161711
    [TBL] [Abstract][Full Text] [Related]  

  • 99. FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.
    Ackermann S; Kocak H; Hero B; Ehemann V; Kahlert Y; Oberthuer A; Roels F; Theißen J; Odenthal M; Berthold F; Fischer M
    BMC Cancer; 2014 Nov; 14():840. PubMed ID: 25406647
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Expression of TBX3 in Hepatocellular Carcinoma and Its Clinical Implication.
    Li Z; Wang Y; Duan S; Shi Y; Li S; Zhang X; Ren J
    Med Sci Monit; 2018 Dec; 24():9324-9333. PubMed ID: 30578408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.